No-donor aspirin derivatives

作者: Roberta Fruttero , Monica Donnola , Loretta Lazzarato , Barbara Rolando , Konstantin Chegaev

DOI:

关键词: Medicinal chemistryNitric oxideAspirinNo donorsChemistry

摘要: The present invention refers to nitric oxide donor aspirin derivatives, a process for their preparation and pharmaceutical compositions containing -them. Formula (I) wherein R is selected from the group consisting of A) (R 0 ) t -CH (ONO 2 -R B) - CH (CR 3 4 P C) -O- n D) P-CH .

参考文章(8)
Peter G. M. Wuts, Theodora W. Greene, Protective groups in organic synthesis ,(1981)
Peter Kurka, Elisabeth Perzborn, Eva Lesur, Oswald Lockhoff, Dieter Neuser, Johannes Peter Stasch, Acetylsalicylic acid nitrates Official Gazette of the United States Patent and Trademark Office Patents. ,vol. 1218, pp. 136912- ,(1996)
Alberto Sala, Aldo Banfi, Francesca Benedini, Roberta Cereda, Benzoic acid substituted derivatives having cardiovascular activity ,(1991)
Dale Gordon Pfizer Global Res. Dev. Mcleod, Anthony Pfizer Global Res. Dev. Marfat, Beta-lactamase inhibitor prodrug ,(2003)
Alfred G. Gilman, George B. Koelle, Alfred Gilman, Louis Sanford Goodman, The pharmacological basis of therapeutics ,(2000)
Costanza Emanueli, Sophie Van Linthout, Maria Bonaria Salis, Angela Monopoli, Piero Del Soldato, Ennio Ongini, Paolo Madeddu, Nitric Oxide–Releasing Aspirin Derivative, NCX 4016, Promotes Reparative Angiogenesis and Prevents Apoptosis and Oxidative Stress in a Mouse Model of Peripheral Ischemia Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 24, pp. 2082- 2087 ,(2004) , 10.1161/01.ATV.0000144030.39087.3B